Medtronic

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medtronic and other ETFs, options, and stocks.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.

CEO

Geoffrey Straub Martha

CEOGeoffrey Straub Martha

Employees

95,000

Employees95,000

Headquarters

Galway, Galway

HeadquartersGalway, Galway

Founded

2014

Founded2014

Employees

95,000

Employees95,000

MDT Key Statistics

Market cap

110.56B

Market cap110.56B

Price-Earnings ratio

26.28

Price-Earnings ratio26.28

Dividend yield

3.22%

Dividend yield3.22%

Average volume

7.80M

Average volume7.80M

High today

$86.39

High today$86.39

Low today

$84.55

Low today$84.55

Open price

$84.92

Open price$84.92

Volume

6.52M

Volume6.52M

52 Week high

$92.68

52 Week high$92.68

52 Week low

$75.96

52 Week low$75.96

MDT News

TipRanks 3d

Medtronic announces FDA clearance for its new InPen app

Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with t...

Simply Wall St 3d

Medtronic Second Quarter 2025 Earnings: Beats Expectations

Medtronic ( ) Second Quarter 2025 Results Key Financial Results Revenue: US$8.40b (up 5.2% from 2Q 2024). Net income: US$1.27b (up 40% from 2Q 2024). Profit...

Benzinga 4d

Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook

Tuesday, Medtronic Plc MDT reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion. The medical device maker reported adjust...

Analyst ratings

49%

of 35 ratings

Buy

48.6%

Hold

45.7%

Sell

5.7%

More MDT News

TipRanks 4d

MDT Earnings: Medtronic Beats Q2 Expectations, Boosts FY25 Guidance

Medtronic (MDT) reported better-than-expected Fiscal Q2 results. The medical device company reported adjusted earnings of $1.26 per share in the Fiscal second q...

Seeking Alpha 4d

Medtronic tightens FY25 guidance amid forex impact

With its Q2 FY25 results, which beat Street forecasts on Tuesday, Medtronic (NYSE:MDT) narrowed its full-year earnings outlook in line with consensus despite an...